Get the Stockscreener App
324.45
2.77%
9.6818
Overview
News
Price History
Option Chain
Financials
Why WST Down?
Discussions
Forecast
Stock Split
Dividend History
West Pharmaceutical Services Inc stock is traded at $324.45, with a volume of 398.77K.
It is up +2.77% in the last 24 hours and up +9.10% over the past month.
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
See More
Previous Close:
$314.77
Open:
$313.5
24h Volume:
398.77K
Relative Volume:
0.74
Market Cap:
$23.89B
Revenue:
$2.88B
Net Income/Loss:
$524.90M
P/E Ratio:
43.79
EPS:
7.41
Net Cash Flow:
$357.10M
1W Performance:
+1.59%
1M Performance:
+9.10%
6M Performance:
-11.38%
1Y Performance:
-3.44%
1-Day Range:
$313.50
$331.82
1-Week Range:
$307.89
$331.82
52-Week Range:
$265.00
$413.70
West Pharmaceutical Services Inc Stock (WST) Company Profile
Name
West Pharmaceutical Services Inc
Sector
Industry
Phone
(610) 594-2900
Address
530 HERMAN O. WEST DRIVE, EXTON, PA
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-11-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Nov-30-22 | Initiated | UBS | Neutral |
| Oct-28-22 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-14-20 | Initiated | Stephens | Equal-Weight |
| Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-24-20 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Dec-12-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| May-01-19 | Downgrade | Jefferies | Buy → Hold |
| Apr-23-19 | Initiated | William Blair | Outperform |
| Apr-25-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-24-18 | Initiated | Goldman | Neutral |
| Oct-17-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-03-17 | Initiated | Stephens | Equal-Weight |
| Sep-15-17 | Upgrade | Jefferies | Hold → Buy |
| Oct-28-16 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Sep-21-16 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Mar-22-16 | Initiated | Wells Fargo | Outperform |
| May-14-10 | Reiterated | UBS | Neutral |
| Feb-23-10 | Initiated | Jefferies & Co | Buy |
| Dec-19-08 | Initiated | UBS | Neutral |
View All
West Pharmaceutical Services Inc Stock (WST) Latest News
Get Ready: West Pharmaceutical Services to Unveil Q3 Financial Results and Insights! - MSN
West Pharmaceutical Services, Inc. (NYSE:WST) Holdings Trimmed by New York State Common Retirement Fund - MarketBeat
New York State Teachers Retirement System Has $20.14 Million Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
WST (West Pharmaceutical Services) Revenue : $2,876 Mil (TTM As of Sep. 2024) - GuruFocus.com
International Assets Investment Management LLC Grows Holdings in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical's VP Charles Witherspoon sells $218,211 in stock - Investing.com India
West Pharmaceutical Services, Inc. (NYSE:WST) VP Sells $218,211.20 in Stock - MarketBeat
West Pharmaceutical's VP Charles Witherspoon sells $218,211 in stock By Investing.com - Investing.com UK
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Congress Asset Management Co. - MarketBeat
West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
West Pharmaceutical Services: Expanding Capacity in High-Value Product Lines & Unlocking Commercial Manufacturing Potential!Major Drivers - Smartkarma
West Pharmaceutical Services (WST) Fell Due to Lower-Than-Expected Results and Reduced Guidance - Insider Monkey
abrdn plc Sells 11,626 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services Reports Solid Third-Quarter 2024 Results and Raises Guidance - MSN
West to Participate in Upcoming Investor Conferences - Marketscreener.com
West to Participate in Upcoming Investor Conferences – Company Announcement - Financial Times
On Body Drug Delivery Devices Market: Anticipated Positive - openPR
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
Buy These 4 Stocks With New Dividend Hikes Amid Market Volatility - MSN
Assenagon Asset Management S.A. Acquires 12,769 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
William Blair Has Negative Estimate for WST Q4 Earnings - MarketBeat
West Pharmaceutical Services, Inc. Just Recorded A 27% EPS Beat: Here's What Analysts Are Forecasting Next - Simply Wall St
What's in Store for West Pharmaceutical in Q3 Earnings? - MSN
Decoding West Pharmaceutical Services Inc (WST): A Strategic SWOT Insight - Yahoo Finance
Decoding West Pharmaceutical Services Inc (WST): A Strategic SWO - GuruFocus.com
West Pharmaceutical Services (NYSE:WST) Announces Earnings Results, Beats Expectations By $0.34 EPS - MarketBeat
West Pharmaceutical Services (NYSE:WST) Stock Price Down 3.6%Should You Sell? - MarketBeat
West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2024 Earnings Call Transcript - MSN
West Pharmaceutical Adjusts 2024 Guidance Amid Sales Dip - Yahoo Finance
West Pharmaceutical Services, Inc. (NYSE:WST) Plans Dividend Increase$0.21 Per Share - MarketBeat
Earnings call: West Pharmaceutical Services outlines Q3 2024 results - Investing.com
West Pharmaceutical Services Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
West Pharmaceutical Stock Gains on Q3 Earnings Beat & Raised Guidance - MSN
Raymond James & Associates Grows Position in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services Inc (WST) Q3 2024 Earnings Call Highlights: Strong Performance ... - Yahoo Finance
West Pharmaceutical Services Inc (WST) Q3 2024 Earnings Call Hig - GuruFocus.com
Tesla, Boeing, UPS, IBM, ServiceNow, Molina, West Pharma, Newmont, and More Movers - Barron's
West Pharmaceutical's Q3 Performance Shows Rising Demand For Syringes, Company Boosts Annual Forecast And Dividend - AOL
West Pharmaceutical Services (NYSE:WST) Shares Gap UpTime to Buy? - MarketBeat
Why Is West Pharmaceutical Stock Soaring On Thursday?West Pharmaceutical Servs (NYSE:WST) - Benzinga
West Pharmaceutical: Q3 Earnings Snapshot - The Washington Post
West Pharmaceutical reports Q3 adjusted EPS $1.85, consensus $1.50 - TipRanks
Monte Financial Group LLC Acquires 1,883 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical gains on annual profit forecast raise - XM
West Pharmaceutical Services Shares Rise 19% after Raising 2024 Outlook - MarketWatch
west pharmaceutical services inc. Positive Earnings Pre-Announcements - RTTNews
West Pharmaceutical raises annual profit forecast on demand for medical supplies - WTVB
West Pharmaceutical Services (NYSE:WST) Updates FY24 Earnings Guidance - MarketBeat
West Pharmaceutical Ups Forecast On Rising Medical Supply Demand - Finimize
West Pharmaceutical Services (WST) Tops Q3 Earnings and Revenue Estimates - Yahoo Finance
West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend – Company AnnouncementFT.com - Financial Times
West Pharmaceutical Services Inc Stock (WST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.44%
3.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):